SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20918)5/16/1998 9:52:00 AM
From: TomOrt  Read Replies (2) | Respond to of 32384
 
all;
check out Barrons today, LGND mentioned in
story on Biotec. TomOrt



To: Henry Niman who wrote (20918)5/16/1998 1:04:00 PM
From: John O'Neill  Respond to of 32384
 
Henry..the Barron's article is great exposure (Thanks Tom).

What do you think the correlation will be for any positive Evista comments (ASCO) to increase market's awareness of LGND's role as potential for drugs to synergize with Evista?? So far the market hasn't seemed to connect LGND much with cancer drugs.

That Barron's article could turn on some investors' brain cells.

JO


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News